Compare Novo Nordisk A/S (NVO) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Roblox Corp — how do they compare? Novo Nordisk A/S trades at $38.64 (market cap $165.31B), while Roblox Corp trades at $48.09 (market cap $32.52B). The key difference: Novo Nordisk A/S is far larger — about 5.1× Roblox Corp's market cap, and Novo Nordisk A/S pays a 4.71% dividend while Roblox Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novo Nordisk A/S for 116 Days and Roblox Corp for 93 Days on average.
| NVO | RBLX | |
|---|---|---|
Market Cap | $165.31B | $32.52B |
Volume | 11,432,838 | 14,552,045 |
Sector | Health | Technology |
52-Week High | $63.98 | $138.56 |
52-Week Low | $35.29 | $35.54 |
Typical Hold Time | 116 Days | 93 Days |
Enterprise Value | $179.56B | $31.34B |
Dividend Yield | 4.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $38.64, up 0.99% with bearish technical signals despite strong fundamentals. The company maintains exceptional profitability with 35.35% net margins and has beaten earnings estimates for three consecutive quarters. Recent news highlights pipeline developments including weight-loss drug advancements and a $4 billion licensing deal expansion.
While facing competitive pressure in obesity treatments, NVO's valuation remains attractive with a 9.66 P/E ratio. Analyst consensus is bullish with a $44.67 price target, representing 15.6% upside potential. Key risks include FDA regulatory delays and intensifying competition from Eli Lilly in the GLP-1 market.
RBLX trades at $48.09, up 3.62% today, showing strong momentum despite a bearish technical signal. The stock has beaten earnings expectations for three consecutive quarters, with revenue growing from $2.2B in 2022 to $4.9B in 2025. However, the company remains unprofitable with a net income margin of -17.61% and negative ROE of -396.28%. Recent news highlights mixed sentiment, including a Jefferies downgrade to Underperform on September 28, 2026, citing concerns about bookings growth, offset by optimism around AI tools unveiled at the developer conference.
The outlook for RBLX hinges on balancing robust revenue growth against persistent losses. The consensus price target of $50.85 suggests modest upside, but high P/B of 213.94 and negative profitability metrics pose risks. Key opportunities include AI-driven creator tools and expanding user engagement, while threats involve booking deceleration and competitive pressure. Investors should weigh the company's growth trajectory against its path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
